<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04809324</url>
  </required_header>
  <id_info>
    <org_study_id>protocol no 3541</org_study_id>
    <secondary_id>CTRI/2021/03/032015</secondary_id>
    <nct_id>NCT04809324</nct_id>
  </id_info>
  <brief_title>Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers</brief_title>
  <official_title>Intra-operative Gross Examination Versus Frozen Section for Achievement of Adequate Margin in Patients Undergoing Surgery for Oral Cavity Squamous Cell Carcinoma: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr.Pankaj Chaturvedi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tata Memorial Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical margin is a significant prognostic factor in oral cavity squamous cell carcinoma&#xD;
      (OCSCC)[1,2,3]. Intra-operative frozen section (FS) has been routinely used by the surgeons&#xD;
      to achieve adequate surgical margins. However published literature has failed to show a&#xD;
      conclusive benefit of FS in improving oncological outcomes(4-7). The overall identification&#xD;
      rate of the inadequate margins by FS is variable with figures in the literature ranging&#xD;
      from25-34%.(8-10)&#xD;
&#xD;
      Revision of margins based on FS is widely practiced in centers where facility for FS is&#xD;
      available. However this has not shown to significantly improve local control when compared to&#xD;
      cases in which FS was not utilized , in a comparative study done at Tata memorial&#xD;
      Hospital(TMH) (5) More-over FS is a costly procedure, and sparsely available in resource-&#xD;
      poor countries. In a recently conducted retrospective study of 1237 patients conducted at&#xD;
      TMH, the cost benefit ratio of FS for assessment of margin is as low as 12:1(11). In another&#xD;
      prospective study performed at the same center , investigators found that gross examination&#xD;
      (GE) of margins by the surgeons was as effective as FS, and achievement of gross 7mm margin&#xD;
      all around the tumor obviated the need for FS (12). In a recent meta-analysis of 8 studies&#xD;
      that looked at the utility of frozen section and had uniformity in frozen section analysis&#xD;
      and definition of close margins, they concluded that revision of margins based on FS does not&#xD;
      improve oncological outcomes and further prospective studies are needed to explore this&#xD;
      contentious issue (13). With this background, a prospective RCT is planned to explore if&#xD;
      gross examination by surgeon and subsequent revision of margin (if necessary) is an equally&#xD;
      effective alternative to Frozen section based revision in a randomized controlled trial.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">June 2028</completion_date>
  <primary_completion_date type="Anticipated">June 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>patient and the treating clinician will not be aware of the randomisation allocation(gross examination or frozen section) prior to resection of the tumour specimen</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>local recurrence free survival (LRFS) between two arms</measure>
    <time_frame>2 years</time_frame>
    <description>To determine the difference between the local recurrence free survival (LRFS) between intra operative gross examination by the surgeon compared with microscopic examination using frozen sections by the pathologist for the assessment of surgical margin in patients undergoing surgery for OCSCC.&#xD;
Local recurrence will be defined as - tumor recurrence at the same subsite or or at margins of previous surgery &amp;/ reconstruction with or without nodal recurrence /distant metastases withing two years after completion of the treatment.&#xD;
- Isolated regional &amp;/or distant metastasis without recurrence at local site will be recorded however it will not be considered as the event for measuring LRFS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy of gross examination</measure>
    <time_frame>5 years</time_frame>
    <description>To determine the accuracy of intra operative gross examination by the surgeon compared with microscopic examination of frozen sections by the pathologist for the assessment of surgical margin as compared to the final histopathology report as the gold standard.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of GE and FS for the assessment of surgical margin</measure>
    <time_frame>5years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1206</enrollment>
  <condition>Oral Cavity Cancer</condition>
  <arm_group>
    <arm_group_label>Gross examination</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>measurement of the surgical margins will be done by the surgeon in the operating room using sterile scale after resection of the primary tumor .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Frozen section</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>frozen section examination of surgical margins will be done by the pathologist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gross examination of the resection specimen</intervention_name>
    <description>measurement of the surgical margin by the operating surgeon using sterile scale, margins &lt;7mm will be revised on table</description>
    <arm_group_label>Gross examination</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Frozen section</intervention_name>
    <description>frozen section evaluation of the specimen by the pathologist</description>
    <arm_group_label>Frozen section</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Biopsy proven treatment na√Øve cases of OCSCC who are planned for curative surgery with&#xD;
             en-bloc removal of the tumor with adequate margin&#xD;
&#xD;
          2. In detail assessment of the primary tumor is possible pre-operatively&#xD;
&#xD;
          3. Written informed consent&#xD;
&#xD;
          4. Age more than 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Multifocal disease&#xD;
&#xD;
          2. Clinically evident field cancerization&#xD;
&#xD;
          3. Previous treatment for oral cavity cancer - Surgery /chemo or radiotherapy -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pankaj Chaturvedi, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tata Memorial Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pankaj Chaturvedi, MS</last_name>
    <phone>+91 02224177189</phone>
    <email>chaturvedi.pankaj@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vidisha V Tuljapurkar, MS MCh</last_name>
    <phone>+91 02224177187</phone>
    <email>vidishavt@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tata Memorial Hospital</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400012</zip>
        <country>India</country>
      </address>
    </facility>
    <contact>
      <last_name>Pankaj Chaturvedi, MS</last_name>
      <phone>+91 9869486912</phone>
      <email>chaturvedi.pankaj@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Deepa Nair, MS,DNB</last_name>
      <phone>+91 0222 02224177282</phone>
      <email>drdeepanair78@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>ACTREC,Advanced Centre for Treatment, Research and Education in Cancer</name>
      <address>
        <city>Navi Mumbai</city>
        <state>Raigad</state>
        <zip>-410210</zip>
        <country>India</country>
      </address>
    </facility>
    <contact>
      <last_name>Sudhir Nair, MS</last_name>
      <phone>9769617780</phone>
      <email>sudhirvr@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mahamana Pandit Madan Mohan Malaviya Cancer Centre</name>
      <address>
        <city>Varanasi</city>
        <state>Uttar Pradesh</state>
        <zip>221005</zip>
        <country>India</country>
      </address>
    </facility>
    <contact>
      <last_name>Assem Mishra, MS,MCh</last_name>
      <phone>8080611946</phone>
      <email>draseemmishra@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Looser KG, Shah JP, Strong EW. The significance of &quot;positive&quot; margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1978 Nov-Dec;1(2):107-11.</citation>
    <PMID>755803</PMID>
  </reference>
  <reference>
    <citation>Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg. 1990 Oct;160(4):410-4.</citation>
    <PMID>2221245</PMID>
  </reference>
  <reference>
    <citation>Chen TY, Emrich LJ, Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys. 1987 Jun;13(6):833-7.</citation>
    <PMID>3583852</PMID>
  </reference>
  <reference>
    <citation>Pathak KA, Nason RW, Penner C, Viallet NR, Sutherland D, Kerr PD. Impact of use of frozen section assessment of operative margins on survival in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Feb;107(2):235-9. doi: 10.1016/j.tripleo.2008.09.028. Epub 2008 Dec 13.</citation>
    <PMID>19071037</PMID>
  </reference>
  <reference>
    <citation>Mair M, Nair D, Nair S, Dutta S, Garg A, Malik A, Mishra A, Shetty Ks R, Chaturvedi P. Intraoperative gross examination vs frozen section for achievement of adequate margin in oral cancer surgery. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 May;123(5):544-549. doi: 10.1016/j.oooo.2016.11.018. Epub 2016 Dec 7.</citation>
    <PMID>28159583</PMID>
  </reference>
  <reference>
    <citation>Kov√°cs AF. Relevance of positive margins in case of adjuvant therapy of oral cancer. Int J Oral Maxillofac Surg. 2004 Jul;33(5):447-53.</citation>
    <PMID>15183407</PMID>
  </reference>
  <reference>
    <citation>Scholl P, Byers RM, Batsakis JG, Wolf P, Santini H. Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications. Am J Surg. 1986 Oct;152(4):354-60.</citation>
    <PMID>3766863</PMID>
  </reference>
  <reference>
    <citation>DiNardo LJ, Lin J, Karageorge LS, Powers CN. Accuracy, utility, and cost of frozen section margins in head and neck cancer surgery. Laryngoscope. 2000 Oct;110(10 Pt 1):1773-6.</citation>
    <PMID>11037842</PMID>
  </reference>
  <reference>
    <citation>Ord RA, Aisner S. Accuracy of frozen sections in assessing margins in oral cancer resection. J Oral Maxillofac Surg. 1997 Jul;55(7):663-9; discussion 669-71.</citation>
    <PMID>9216496</PMID>
  </reference>
  <reference>
    <citation>Ribeiro NF, Godden DR, Wilson GE, Butterworth DM, Woodwards RT. Do frozen sections help achieve adequate surgical margins in the resection of oral carcinoma? Int J Oral Maxillofac Surg. 2003 Apr;32(2):152-8.</citation>
    <PMID>12729775</PMID>
  </reference>
  <reference>
    <citation>Datta S, Mishra A, Chaturvedi P, Bal M, Nair D, More Y, Ingole P, Sawakare S, Agarwal JP, Kane SV, Joshi P, Nair S, D'Cruz A. Frozen section is not cost beneficial for the assessment of margins in oral cancer. Indian J Cancer. 2019 Jan-Mar;56(1):19-23. doi: 10.4103/ijc.IJC_41_18.</citation>
    <PMID>30950438</PMID>
  </reference>
  <reference>
    <citation>Chaturvedi P, Datta S, Nair S, Nair D, Pawar P, Vaishampayan S, Patil A, Kane S. Gross examination by the surgeon as an alternative to frozen section for assessment of adequacy of surgical margin in head and neck squamous cell carcinoma. Head Neck. 2014 Apr;36(4):557-63. doi: 10.1002/hed.23313. Epub 2013 Jun 14.</citation>
    <PMID>23765548</PMID>
  </reference>
  <reference>
    <citation>Bulbul MG, Tarabichi O, Sethi RK, Parikh AS, Varvares MA. Does Clearance of Positive Margins Improve Local Control in Oral Cavity Cancer? A Meta-analysis. Otolaryngol Head Neck Surg. 2019 Aug;161(2):235-244. doi: 10.1177/0194599819839006. Epub 2019 Mar 26.</citation>
    <PMID>30912991</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 18, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tata Memorial Centre</investigator_affiliation>
    <investigator_full_name>Dr.Pankaj Chaturvedi</investigator_full_name>
    <investigator_title>Dr Pankaj Chaturvedi ,Prof. and Surgeon, Dept of Head Neck Surgery</investigator_title>
  </responsible_party>
  <keyword>Oral squamous Cell carcinoma</keyword>
  <keyword>frozen section</keyword>
  <keyword>local recurrence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Beginning 3 months and ending 5 years following article publication.</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal To achieve aims in the approved proposal for individual participant data meta-analysis.&#xD;
Proposals should be directed to chaturvedi.pankaj@gmail.com. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

